Residential School on Medicinal Chemistry and Biology in Drug Discovery
DATES ANNOUNCED for 2018: June 10-15, 2018
The Residential School on Medicinal Chemistry and Biology in Drug Discovery is designed for chemists and biologists interested in broadening their understanding of the fundamental principles of drug discovery research and preclinical development. Scientists from related disciplines would also gain a clearer appreciation for the processes and methods important to drug discovery through clinical development.
Once again, we are proud to announce that our Hotel Resident attendees will be staying at The Madison Hotel. There will be a shuttle to transport attendees to and from the campus.
Feedback from Previous Attendees
“Loved the course. Gained a lot in 4 1/2 days. The whole experience was wonderful. I will recommend the course to all my colleagues who haven’t taken it.”
“By far the most useful short course/seminar that I have been to.”
“Very helpful, practical, informative, a must for all newcomers to the pharma industry.”
“Overall, a great experience. Talks, both lectures and case studies, were current and very useful. I learned a lot and will apply it daily at work.”
“Everyone needs to take this course.”
Topics for 2017 ResMed (2018 Program to be determined)
- Principles of Med Chem
- Enzyme Inhibition
- Kinase Inhibitors
- G-Protein Coupled Receptors
- Receptor Binding Assays
- Drugs Affecting Ion Channels
- Hit-to-Lead Process in Drug Discovery
- Princ. of Lead Optimization
- Drug-like Properties in Drug Discovery
- Fragment-based Drug Design
- Molecular Modeling
- Structure-Based Drug Design
- Protein-Protein Interactions
- Drug Metabolism
- Improving Drug Candidates by Design
- Designing Around Toxicophores
- Preclinical Toxicology
- Clinical Development
- Four Case History Presentations
ResMed: Residential School on Medicinal Chemistry and Biology in Drug Discovery is a week-long graduate level course organized to provide an accelerated program for medicinal chemists, biologists and other industrial and academic scientists who wish to broaden their knowledge of drug discovery and development. The School’s aim is to concentrate on the fundamentals that are useful in drug discovery spanning initial target validation through clinical development.
Most chemists and biologists have received little formal training in the range of subjects required for drug discovery. These topics include target selection, assay development, initial identification of active “hit” compounds, development of structure-activity relationships, lead optimization, pharmacokinetics, pharmacodynamics, metabolism, toxicology and clinical development.
Although drug discovery is an interdisciplinary subject, the course is more than a simple compendium of information. It will concentrate on the fundamental issues common to a wide range of therapeutic areas. The purpose of the School is to impart the basic principles needed by both chemists and biologists to pursue successful collaborative drug discovery programs.
The week-long course is structured around lectures and case histories that illustrate the discovery and development of recent successful drug discovery programs. There will be ample opportunity for questions and discussions with faculty members. The School not only provides an atmosphere of learning and understanding but also the opportunity to establish contacts with colleagues from many different organizations, which is an important component of a successful career in drug discovery. The ResMed Faculty is comprised of distinguished scientists from industry and academia with years of experience and success in drug discovery and development.